Biometrics
-
Publication Venue For
- Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded.. 78:848-851. 2022
- A general framework for subgroup detection via one-step value difference estimation. 2022
- Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease.. 78:435-447. 2022
- Multisource single-cell data integration by MAW barycenter for Gaussian mixture models. 2022
- Joint gene network construction by single-cell RNA sequencing data. 2022
- Improving trial generalizability using observational studies. 2021
- Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial. 2021
- Estimating vaccine efficacy over time after a randomized study is unblinded. 2021
- Group sequential testing for cluster randomized trials with time-to-event endpoint. 2021
- Bayesian shrinkage estimation of high dimensional causal mediation effects in omics studies.. 76:700-710. 2020
- Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.. 74:1180-1192. 2018
- Sample size determination for GEE analyses of stepped wedge cluster randomized trials.. 74:1450-1458. 2018
- Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach.. 74:900-909. 2018
- Report of the Editors-2017.. 74:5-7. 2018
- Biometrics, JABES and the International Biometric Society.. 73:723-724. 2017
- Estimating optimal shared-parameter dynamic regimens with application to a multistage depression clinical trial.. 72:865-876. 2016
- PenPC: A two-step approach to estimate the skeletons of high-dimensional directed acyclic graphs.. 72:146-155. 2016
- Using decision lists to construct interpretable and parsimonious treatment regimes.. 71:895-904. 2015
- A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies.. 71:529-537. 2015
- Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records.. 71:478-486. 2015
- Response to reader reaction.. 71:267-273. 2015
- Discussion of "Combining biomarkers to optimize patient treatment recommendation".. 70:707-710. 2014
- Evaluating marker-guided treatment selection strategies.. 70:489-499. 2014
- Assessing the causal effect of organ transplantation on the distribution of residual lifetime.. 69:820-829. 2013
- Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.. 69:830-839. 2013
- A robust method for estimating optimal treatment regimes.. 68:1010-1018. 2012
- Biometrics. Report of the editors--2011.. 68:vii-x. 2012
- A moment-adjusted imputation method for measurement error models.. 67:1461-1470. 2011
- Insights on the robust variance estimator under recurrent-events model.. 67:1564-1572. 2011
- Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout.. 67:536-545. 2011
- A penalized likelihood approach for bivariate conditional normal models for dynamic co-expression analysis.. 67:299-308. 2011
- A generalized estimator of the attributable benefit of an optimal treatment regime.. 66:512-522. 2010
- Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling.. 66:502-511. 2010
- Regression on quantile residual life.. 65:1203-1212. 2009
- Shrinkage-based diagonal discriminant analysis and its applications in high-dimensional data.. 65:1021-1029. 2009
- Bayesian inference for smoking cessation with a latent cure state.. 65:970-978. 2009
- Gene-trait similarity regression for multimarker-based association analysis.. 65:822-832. 2009
- Latent-model robustness in joint models for a primary endpoint and a longitudinal process.. 65:719-727. 2009
- Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials.. 64:1247-1255. 2008
- Improving efficiency of inferences in randomized clinical trials using auxiliary covariates.. 64:707-715. 2008
- "Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data.. 64:567-576. 2008